Minneapolis
89°F
eEdition
News & Politics
Sports
Food & Culture
Business
Outdoors
Opinion
Things To Do
Obituaries
More of What Matters to Minnesota
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Minnesota State Top Stocks
Markets
Minnesota Stocks
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Vaxcyte Inc
(NQ:
PCVX
)
78.14
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 22, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Vaxcyte Inc
< Previous
1
2
3
4
Next >
Vaxcyte to Present at Upcoming Investor Conferences
November 03, 2022
From
Vaxcyte, Inc.
Via
GlobeNewswire
Why Investors Are Suddenly Excited About Vaxcyte
October 31, 2022
Vaxcyte, Inc. is a small cap biotech company that catapulted back to mid-cap land with a stunning 110% surge — and may not be done yet.
Via
MarketBeat
Exposures
COVID-19
Why Shares of Vaxcyte Rose 110.7% This Week
October 29, 2022
The company released early data for a promising pneumonia vaccine.
Via
The Motley Fool
Vaxcyte Announces Closing of $690 Million Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
October 28, 2022
From
Vaxcyte, Inc.
Via
GlobeNewswire
Earnings Scheduled For February 28, 2022
February 28, 2022
Companies Reporting Before The Bell • Lexicon Pharmaceuticals (NASDAQ:LXRX) is estimated to report earnings for its fourth quarter. • Praxis Precision Medicine (...
Via
Benzinga
Wingstop, Harley-Davidson, Rollins And Some Other Big Stocks Moving Higher On Wednesday
October 26, 2022
U.S. stocks traded mixed, with the Dow Jones gaining more than 200 points on Wednesday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Vaxcyte Announces Pricing of $600 Million Public Offering
October 26, 2022
From
Vaxcyte, Inc.
Via
GlobeNewswire
Avis Budget, Scholastic And Other Big Gainers From Monday
October 25, 2022
U.S. stocks closed higher on Monday, with the Dow Jones gaining over 400 points. Here is the list of some big stocks recording gains in the previous session.
Via
Benzinga
Why Tricida Shares Dipped Around 95%; Here Are 73 Biggest Movers From Yesterday
October 25, 2022
Gainers Applied Genetic Technologies Corporation (NASDAQ: AGTC) climbed 62.4% to close at $0.39. Syncona disclosed that it will acquire Applied Genetic Technologies Corporation.
Via
Benzinga
Vaxcyte Announces Commencement of Proposed Public Offering of Common Stock and Pre-Funded Warrants
October 24, 2022
From
Vaxcyte, Inc.
Via
GlobeNewswire
Dow Rises 1.5%; Nasdaq Jumps Over 100 Points
October 24, 2022
U.S. stocks traded higher toward the end of trading, with the Dow Jones surging more than 450 points on Monday.
Via
Benzinga
Why Vaxcyte Shares Are Trading Sharply Higher? Here Are 63 Stocks Moving In Monday's Mid-Day Session
October 24, 2022
Gainers Vaxcyte, Inc. (NASDAQ: PCVX) shares jumped 65% to $33.96 after the company announced positive topline results from the Phase 1/2 clinical proof-of-concept study evaluating the safety,...
Via
Benzinga
Nasdaq Turns Higher; Applied Genetic Technologies Shares Surge
October 24, 2022
U.S. stocks traded mostly higher midway through trading, with the Dow Jones surging more than 300 points on Monday.
Via
Benzinga
Vaxcyte Shares Surge As Its Pneumococcal Vaccine On Par With Pfizer's Shot In Study
October 24, 2022
Via
Benzinga
Why Is Tricida (TCDA) Stock Down 90% Today?
October 24, 2022
Tricida (TCDA) stock is falling on Monday following the release of poor results from a Phase 3 chronic kidney disease clinical trial.
Via
InvestorPlace
How Is The Market Feeling About Vaxcyte?
October 24, 2022
Vaxcyte's (NASDAQ:PCVX) short percent of float has risen 22.85% since its last report. The company recently reported that it has 2.48 million shares sold short, which is 5.43% of all regular shares...
Via
Benzinga
Why Is Vaxcyte (PCVX) Stock Up 70% Today?
October 24, 2022
Vaxcyte (PCVX) stock is rocketing higher on Monday after the vaccine company revealed positive data from a Phase 1/2 clinical trial.
Via
InvestorPlace
US Stocks Mixed; Dow Jumps 200 Points
October 24, 2022
U.S. stocks traded mixed this morning, with the Dow Jones surging around 200 points on Monday.
Via
Benzinga
Vaxcyte Shares Are Soaring: Here's Why
October 24, 2022
Vaxcyte Inc (NASDAQ: PCVX) shares are trading higher Monday after the company announced positive topline results from the Phase 1/2 clinical proof-of-concept study evaluating the safety, tolerability...
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
October 24, 2022
Gainers Applied Genetic Techs (NASDAQ:AGTC) shares moved upwards by 62.0% to $0.39 during Monday's pre-market session. The company's market cap stands at $26.3 million.
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
October 24, 2022
Good morning, traders! We're starting off the week with a breakdown of the biggest pre-market stock movers for Monday morning!
Via
InvestorPlace
Vaxcyte Reports Positive Topline Data from Phase 1/2 Proof-of-Concept Study of its 24-Valent Pneumococcal Conjugate Vaccine Candidate Being Investigated for the Prevention of Invasive Pneumococcal Disease in Adults Aged 18-64
October 24, 2022
From
Vaxcyte, Inc.
Via
GlobeNewswire
Vaxcyte to Host Webcast and Conference Call to Discuss Topline Results from the Phase 1/2 Proof-of-Concept Study of VAX-24 Being Investigated for the Prevention of Invasive Pneumococcal Disease in Adults
October 23, 2022
From
Vaxcyte, Inc.
Via
GlobeNewswire
Vaxcyte Expands Executive Leadership Team with Key Appointments
October 11, 2022
From
Vaxcyte, Inc.
Via
GlobeNewswire
Vaxcyte Completes Enrolment In Mid-Stage Pneumococcal Disease Study, Sees Top-line Data In H1 2013
September 06, 2022
Vaxcyte (NASDAQ: PCVX) has completed patient enrollment in the Phase 2 study evaluating VAX-24 in healthy adults 65 years of age and older. VAX-24 is its lead, 24-valent pneumococcal conjugate vaccine...
Via
Benzinga
Recap Of Thursday's Biotech Catalysts - End Of the Day Summary
August 04, 2022
The European Commission (EC) has approved AstraZeneca (NASDAQ: AZN) and Merck’s (NYSE: MRK) LYNPARZA as monotherapy or in combination with endocrine therapy for the adjuvant treatment of adult patients...
Via
Benzinga
Vaxcyte Concludes Enrolment In Mid-Stage Pneumococcal Disease Study
July 12, 2022
Vaxcyte (NASDAQ: PCVX) completed patient enrollment in the Phase 2 portion of the ongoing Phase 1/2 proof-of-concept study evaluating VAX-24 in healthy adults 50 to 64 years of age.
Via
Benzinga
48 Biggest Movers From Yesterday
January 14, 2022
Gainers Singularity Future Technology Ltd. (NASDAQ: SGLY) shares rose 25.9% to settle at $5.01 on Thursday. MedAvail Holdings, Inc (NASDAQ: MDVL) gained 24.4% to settle at $1.58...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
January 13, 2022
Gainers Stealth BioTherapeutics (NASDAQ:MITO
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
January 13, 2022
Gainers Rockwell Medical (NASDAQ:RMTI) st...
Via
Benzinga
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.